Onchocerciasis (River Blindness) - Pipeline Review, H2 2011 by GlobalMarketsDirect

VIEWS: 4 PAGES: 17

More Info
									Onchocerciasis (River Blindness) – Pipeline Review, H2 2011




    Onchocerciasis (River Blindness) - Pipeline Review,
                         H2 2011
                                                                                          Reference Code: GMDHC1592IDB

                                                                                          Publication Date: November 2011




Onchocerciasis (River Blindness) – Pipeline Review, H2 2011                                                   GMDHC1592IDB / Pub November 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                                                Page(1)
Onchocerciasis (River Blindness) – Pipeline Review, H2 2011



Ta b le o f Co n te n ts
Table of Contents ..................................................................................................................................................................................................... 2
      List of Tables...................................................................................................................................................................................................... 2
      List of Figures .................................................................................................................................................................................................... 3
Introduction .............................................................................................................................................................................................................. 4
      Global Markets Direct Report Coverage ............................................................................................................................................................. 4
Onchocerciasis (River Blindness) Overview ............................................................................................................................................................. 5
Therapeutics Development ....................................................................................................................................................................................... 6
      An Overview of Pipeline Products for Onchocerciasis (River Blindness)............................................................................................................. 6
Onchocerciasis (River Blindness) Therapeutics under Investigation by Universities/Institutes .................................................................................. 8
Mid Clinical Stage Products ...................................................................................................................................................................................... 9
      Comparative Analysis ........................................................................................................................................................................................ 9
Onchocerciasis (River Blindness) Therapeutics - Products under Investigation by Universities/Institutes ................................................................10
      Assessment by Combination Products ..............................................................................................................................................................11
      Assessment by Molecule Type ..........................................................................................................................................................................12
Drug Profiles ...........................................................................................................................................................................................................14
      Rifampin + Azithromycin - Drug Profile ..............................................................................................................................................................14
            Product Description ....................................................................................................................................................................................14
            Mechanism of Action...................................................................................................................................................................................14
            R&D Progress .............................................................................................................................................................................................14
Onchocerciasis (River Blindness) Therapeutics - Discontinued Products.................................................................................................................15
Appendix .................................................................................................................................................................................................................16
  
								
To top